Christopher B. Primiano Net Worth & Insider Trades

Christopher B. Primiano - EVP, Karyopharm Therapeutics Inc

As of December 3, 2020

What is Christopher B. Primiano's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's EVP, Christopher B. Primiano, is estimated to be about $5.45M . Christopher B. Primiano owns about 4,523 units of Karyopharm Therapeutics Inc common stock. In the last 6 years at Karyopharm Therapeutics Inc, Christopher B. Primiano has sold an estimated value of $5.23M worth.

What is Christopher B. Primiano's Past Insider Trading?

Christopher B. Primiano's largest purchase order was 137,061 units , worth over $1.43M on December 3, 2020. Christopher B. Primiano's largest sale order was 137,061 units , worth over $2.4M on December 3, 2020. In total, Christopher B. Primiano has made about 34 transactions over 6 years of their time at Karyopharm Therapeutics Inc. Christopher B. Primiano usually trades in November and February, with the busiest year in 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Christopher B. Primiano's' Mailing Address?

  • Mailing address is C/o Karyopharm Therapeutics Inc. 85 Wells Avenue, Second Floor Newton MA 02459 MA

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on October 5, 2022 by Richard Paulson who sold 3,488 units worth $20.47K . In the last 9 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $147.8M and bought an estimated value of $33.44M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1